Page results
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This is information for women who have been given a diagnosis of adenomyosis.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Advice on socialising and managing friendships for young people living with fatigue conditions.
-
An online talk about being active. The talk is for people who have recently finished cancer treatment at UCLH
-
Here you find all of our information leaflets which will help with day to day diabetes management including managing highs and lows, sick day rules and managing school days including the most up to date school care plans. You will also find information on how to upload your devices at home.
-
Komal Khuti-Dullaart is one of more than 300,000 patients using MyCare UCLH, our app and online service to help manage patient care.
File results
-
FOI/2024/0446 - Skin cancer treatment times 2019/20-2023/24
-
FOI/2024/0458 - Infected blood products, patient numbers 2019/20-2023/24
-
FOI/2024/0577 - Diffuse Large B Cell Lymphoma treatments
-
FOI/2024/0578 - Public identity insurance policies held by Fertility Clinic that cover data breaches
-
FOI/2024/0580 - Newborns taken into care from the maternity wards 2019-2023
-
FOI/2024/0581 - Weight management services/ bariatric surgery/ access to Wegovy
-
FOI/2024/0582 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2024/0583 - National inpatient survey improvements/ night-time noise levels/ ward lighting/ mealtime support
-
FOI/2024/0584 - Immunology Hidradenitis Suppurativa (HS) treatments
-
FOI/2024/0586 - Subject Access Requests (SAR) and Freedom of Information (FOI) requests for 2023/24